rs567709615

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PP3_Strong

The NM_174878.3(CLRN1):​c.433+1061A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000824 in 1,534,600 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00084 ( 1 hom. )

Consequence

CLRN1
NM_174878.3 intron

Scores

7
Splicing: ADA: 1.000
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7

Conservation

PhyloP100: 0.118

Publications

2 publications found
Variant links:
Genes affected
CLRN1 (HGNC:12605): (clarin 1) This gene encodes a protein that contains a cytosolic N-terminus, multiple helical transmembrane domains, and an endoplasmic reticulum membrane retention signal, TKGH, in the C-terminus. The encoded protein may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIIa. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
SIAH2-AS1 (HGNC:40526): (SIAH2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLRN1NM_174878.3 linkc.433+1061A>T intron_variant Intron 2 of 2 ENST00000327047.6 NP_777367.1 P58418-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLRN1ENST00000327047.6 linkc.433+1061A>T intron_variant Intron 2 of 2 1 NM_174878.3 ENSP00000322280.1 P58418-3
ENSG00000260234ENST00000569170.5 linkn.160+1061A>T intron_variant Intron 1 of 10 1 ENSP00000457784.1 H3BUT2

Frequencies

GnomAD3 genomes
AF:
0.000657
AC:
100
AN:
152234
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00121
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000507
AC:
68
AN:
134166
AF XY:
0.000411
show subpopulations
Gnomad AFR exome
AF:
0.000156
Gnomad AMR exome
AF:
0.0000411
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.00121
Gnomad OTH exome
AF:
0.000242
GnomAD4 exome
AF:
0.000843
AC:
1165
AN:
1382366
Hom.:
1
Cov.:
30
AF XY:
0.000831
AC XY:
567
AN XY:
682132
show subpopulations
African (AFR)
AF:
0.000127
AC:
4
AN:
31568
American (AMR)
AF:
0.0000841
AC:
3
AN:
35664
Ashkenazi Jewish (ASJ)
AF:
0.0000796
AC:
2
AN:
25140
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35690
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79066
European-Finnish (FIN)
AF:
0.0000590
AC:
2
AN:
33876
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5692
European-Non Finnish (NFE)
AF:
0.00104
AC:
1117
AN:
1077844
Other (OTH)
AF:
0.000640
AC:
37
AN:
57826
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
51
102
154
205
256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000657
AC:
100
AN:
152234
Hom.:
0
Cov.:
32
AF XY:
0.000565
AC XY:
42
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.000338
AC:
14
AN:
41456
American (AMR)
AF:
0.0000654
AC:
1
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00121
AC:
82
AN:
68048
Other (OTH)
AF:
0.00143
AC:
3
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000753
Hom.:
0
Bravo
AF:
0.000642
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00156
AC:
6
ExAC
AF:
0.0000617
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Nov 07, 2018
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.434-2A>T variant in CLRN1 has been previously identified by our laboratory in five individuals with hearing loss, but none of these individuals had a vari ant affecting the remaining copy of the CLRN1 gene. This variant has been identi fied in 0.12% (81/68182) of European chromosomes by the Genome Aggregation Datab ase (http://gnomad.broadinstitute.org/). This variant is located at the -2 splic e site position near exon 3 of an alternate transcript (NM_001195794.1) of the C LRN1 gene, and is predicted to impact splicing of this transcript. However, in a ll other transcripts of the gene, including the major transcript (NM_174878.2), the variant lies in an intronic region that is distant from the splice sites of exons expressed in those transcripts and is not predicted to impact their splici ng. While this alternate transcript (NM_001195794.1) is reportedly expressed in the retina (Vastinsalo 2011), to date, pathogenic variants have not been reporte d in exon 3 of this transcript in individuals with Usher syndrome. Therefore, it is not clear whether abnormal splicing affecting only the alternate transcript can cause disease. In summary, the clinical significance of this variant is unce rtain. ACMG/AMP Criteria applied: PP3, BS1_Supporting. -

Optic atrophy Uncertain:1
Jan 01, 2023
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Uncertain:1
Sep 12, 2016
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.434-2A>T variant in the CLRN1 gene has been reported previously in an individual with Usher syndrome, however a second variant was not identified (Bonnet et al., 2016). This splice site variant destroys the canonical splice acceptor site in intron 2. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. The c.434-2A>T variant was not observed with any significant frequency in the Exome Aggregation Consortium (ExAC) data set, indicating it is not a common benign variant. We interpret c.434-2A>T as a variant of uncertain significance. -

Hearing impairment Uncertain:1
Apr 12, 2021
Department of Otolaryngology – Head & Neck Surgery, Cochlear Implant Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PVS1_Strong, PM2_Supporting, BP4_Supporting -

Retinal dystrophy Uncertain:1
Jan 01, 2023
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Usher syndrome type 3A Uncertain:1
Dec 15, 2016
Counsyl
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Retinitis pigmentosa Uncertain:1
Jan 16, 2019
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was classified as: Uncertain significance. The available evidence favors the benign nature of this variant, however the evidence is insufficent to prove its benign nature. The following ACMG criteria were applied in classifying this variant: PM2. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
20
DANN
Benign
0.91
Eigen
Benign
0.17
Eigen_PC
Benign
-0.23
FATHMM_MKL
Benign
0.029
N
PhyloP100
0.12
GERP RS
0.65
Mutation Taster
=61/39
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.76
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs567709615; hg19: chr3-150658308; API